Solara Active Pharma Sciences Ltd

Capital Structure Change

Solara Active Pharma Sciences Capital Structure Change

Solara Active Pharma Sciences approved the conversion of 2,79,582 partly paid-up rights shares into fully paid-up equity. The conversion followed receipt of pending first and final call monies.

Value

₹3.89 Cr

Capital Structure Change

Solara Active Pharma Sciences Capital Structure Change

Solara Pharma issued a final reminder for unpaid call money on rights shares. Failure to pay by July 27, 2026, will lead to forfeiture of those shares.